Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior

Parathyroid Carcinoma Clinical Trial

Official title:

Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03046524
• Other study ID #: PA15-0808
• Status: Completed
• Phase: N/A
• First received: February 2, 2017
• Last updated: February 6, 2018
• Start date: October 6, 2015
• Est. completion date: October 16, 2017

Study information

• Verified date: February 2018
• Source: M.D. Anderson Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Objectives:

1. Identify the clinical characteristics of parathyroid (PTH) cancer and PTH atypical neoplasms

2. Investigate if PTH carcinoma and atypical neoplasm present a biological behaviour and have a different impact on the health of the patients

Description:

Data between the years of 1/1/2002 and 12/31/2013 will be analyzed. The medical records of all adult patients that had a parathyroidectomy for primary PHPT in MD Anderson Cancer Center will be screened in order to identify patients that had a histopathological diagnosis of parathyroid carcinoma or atypical parathyroid neoplasm.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: October 16, 2017
• Est. primary completion date: October 16, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• All patients from MDACC diagnosed with PHPT that have a histopathological diagnosis of PTH carcinoma or atypical parathyroid neoplasm between the years 1/1/2002 and 12/31/2013

Exclusion Criteria:

• Pediatric patients

• Cases with incomplete records

• Patients where the follow-up will be less than six months

Related Conditions & MeSH terms

• Neoplasms
• Parathyroid Carcinoma
• Parathyroid Neoplasm
• Parathyroid Neoplasms

Intervention

Other:
• Chart Review
Data between the years of 1/1/2002 and 12/31/2013 analyzed.

Locations

Country	Name	City	State
United States	University of Texas MD Anderson Cancer Center	Houston	Texas

Sponsors (1)

Lead Sponsor	Collaborator
M.D. Anderson Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Information Collected on Clinical Characteristics of Parathyroid (PTH) Cancer and PTH Atypical Neoplasms by Conducting a Retrospective Chart Review		5 years
Primary	Information Collected on PTH Carcinoma's Biological Behaviour and Impact on the Health of the Patients by Conducting a Retrospective Chart Review		5 years
Primary	Information Collected on Atypical Neoplasm's Biological Behaviour and Impact on the Health of the Patients \by Conducting a Retrospective Chart Review		5 years

External Links

•   University of Texas MD Anderson Cancer Center Website